Research
The main areas of research of the Department of Medical Sciences are:
Translational and clinical research: analysis of the genetic basis and pathologic physiology of rare and common human diseases, development of novel diagnostic markers and improved therapeutic approaches, applied to
- cardiac arrhythmias
- asthma and chronic lung diseases
- atherosclerosis
- diabetes and metabolic diseases (diabetic retinopathy and nephropathy, cardiovascular risk and models of self-management education)
- hypertension (essential, secondary, heredofamilial)
- skin diseases: melanoma, primary cutaneous T cell lymphoma
- endocrine and metabolic disorders
- liver disease (viral, metabolic, fatty liver disease, cirrhosis)
- gastrointestinal diseases (gastritis, ulcer, inflammatory bowel disease)
- genetic and genomic diseases
- diseases of the Immune System (autoimmune diseases, Mast Cell activation syndrome)
- infectious diseases, pharmacokinetics of anti-infective therapy
- bone metabolic disease
- emergency medicine
- kidney disease
- cancer and inherited genetic predisposition to cancer; endocrine tumors, breast cancer, neurologic cancers, prostate cancer, bowel and liver cancer, lymphoproliferative syndromes, multiple myeloma.
- neuromuscular wellness and physical exercise
Epidemiology and risk-factor analysis applied to:
- cancer
- diabetes
- viral hepatitis
- inflammatory bowel disease
- multifactorial diseases (gene/environment interaction)
- epigenetics of cancer and cardiovascular disease
Transplantation and regenerative medicine:
- histopathology and genetics of transplantation
- stem cells and angiogenesis
- tissue engineering by shock wave therapy and stem cells
- risk factors for non-melanoma cutaneous cancer in immunosuppressed patients
- physical methods and medical devices for regenerative medicine
Diagnostics and imaging:
- nuclear medicine
- digital imaging in pathology; development and validation of methods for conserving human tissues
- development and validation of biomarkers and molecular diagnostics
The Department of Medical Sciences collaborates with The Human Genetics Foundation (HuGeF - Torino) in studying human genomic variability and epigenomics in disease (notably in cancer and cardiovascular disease), and new approaches for the treatment of multiple myeloma.